Trial Profile
Phase III trial of nitazoxanide + oseltamivir in the treatment of acute uncompllicated influenza.
Status:
Not yet recruiting
Phase of Trial:
Phase III
Latest Information Update: 13 Mar 2014
Price :
$35
*
At a glance
- Drugs Nitazoxanide (Primary) ; Oseltamivir
- Indications Influenza virus infections
- Focus Therapeutic Use
- Sponsors Romark Laboratories
- 13 Mar 2014 New trial record